In Denmark, it is only the most recent national guidelines for chronic heart failure treatment from earlier this year that have advocated for SGLT2 inhibitor drug use before patients were fully up-titrated with the common HF medications, including ACEi/ARB, beta-blockers, and MRA drugs. Here, SLC5A2 is linked to congestive heart failure.